Role Cytosolic Glyceraldehyde-3-Phosphate Dehydrogenase Visceral Organ Infection Leishmania donovani
Wen-Wei Zhang, Laura-Isobel McCall, Greg Matlashewski
Department Microbiology Immunology, McGill University, Montreal, Canada
 initial 7 steps glycolytic pathway glucose 3-phosphoglycerate localized glycosomes Leishmania,
including step 6, catalyzed enzyme glyceraldehyde-3-phosphate dehydrogenase (GAPDH). L. donovani L. mexi-
cana, exists second GAPDH enzyme present cytosol absent L. braziliensis pseudo-
gene L. major. investigate role cytosolic GAPDH (cGAPDH), L. donovani cGAPDH-null mutant gener-
ated, conversely, functional L. donovani cGAPDH introduced L. major resulting engineered parasites characterized. L. donovani cGAPDH-null mutant able proliferate rate wild-type parasite glucose-deficient medium.  presence glucose, L. donovani cGAPDH-null mutant consumed glucose proliferated slowly wild-type parasite displayed reduced infectivity visceral organs experimentally
infected mice. demonstrates cGAPDH functional L. donovani required survival visceral organs. Res-
toration cGAPDH activity L. major, contrast, adverse effect L. major proliferation glucose-containing 
dium, providing possible explanation evolved pseudogene L. major. study indicates difference glucose metabolism L. donovani L. major, represent important factor ability L. donovani cause visceral disease.



U     nlike higher eukaryotic cells, glycolytic meta-
      bolic process takes place cytosol, protozoan Kineto-
plastida, Trypanosoma Leishmania, glycolytic path-
                                                                                      transfer occurred divergence Trypanosoma                                                                                       Leishmania (24â€“26).
                                                                                          Considering GAPDH PGK activities detected
way localized mainly specialized organelles called glycosomes                   cytosol T. brucei L. mexicana glycolytic
(1â€“8). enzymes glycolytic pathway Kinetoplastida                    intermediates equilibrate glycosome membranes
glycosomes shown Fig. 1 (4, 5). Glyceraldehyde-3-phosphate                     cytosol, possibly pore-forming channels (27,
dehydrogenase (GAPDH) (EC 1.2.1.12) enzyme catalyzes                      28), glyceraldehyde 3-phosphate derived sixth step glycolysis converting glyceraldehyde 3-phosphate                 active pentose phosphate pathway present cytosol (29, 30),
(GAP) D-glycerate 1,3-bisphosphate (1,3BPGA).                           parallel glycolytic pathway beginning sixth step modeling glycolytic flux bloodstream form Trypanosoma brucei                    glycolysis place cytosol trypanosomes suggests GAPDH phosphoglycerate kinase (PGK)                           Leishmania species expressing cGAPDH (31, 32) (Fig. 1).
zymes partly control glycolytic flux (9â€“11). crystal                   present study, cGAPDH L. donovani investi-
structures T. brucei, Trypanosoma cruzi, Leishmania mexicana                   gated, including necessary visceral infection. glycosomal GAPDHs determined (12â€“14). Inhibitors                       investigated effect adding functional cGAPDH
selectively block trypanosome glycosomal GAPDH activity,                      L. major. study demonstrates cGAPDH human GAPDH, shown kill bloodstream T.                           enzyme represents evolutionary difference L. don-
brucei intracellular T. cruzi (10, 15â€“17).                                        ovani L. major difference plays role ability
    Kinetoplastida glycolytic pathway takes place                        L. donovani survive visceral organs.
predominantly glycosomes, GAPDH activity                                                                                       MATERIALS METHODS
detected cytosol T. brucei L. mexicana (18â€“20).                                                                                       Leishmania strains culture conditions. L. donovani 1S/Cl2D
copies glycosomal GAPDH (gGAPDH) genes tandem array
                                                                                      (MHOM/SD/62/1SCl2D) L. major Friedlin V9 strains used copy cytosolic GAPDH (cGAPDH)-encoding gene                            study. Leishmania promastigote culture medium L. donovani identified T. brucei L. mexicana (18, 21).                           axenic amastigote culture medium glucose described previ-
gGAPDH- cGAPDH-encoding genes identi-                              ously (33â€“36). RPMI glucose-deficient medium contains 1â«» RPMI
fied Leishmania infantum Leishmania donovani.                         1640 medium glucose (Sigma R1383), 10  heat-inactivated glu-
ingly, cGAPDH gene evolved pseudogene Leish-                        cose-deficient fetal bovine serum (FBS) (dialyzed 0.15 M NaCl
mania major completely absent Leishmania braziliensis                       10,000-molecular-weight-cutoff cartridge; Sigma F0392), 100-
(22, 23). gGAPDH enzymes contain sequences glyco-
somal targeting signals. gGAPDH cGAPDH isoenzymes
share 55  identity amino acid sequence, based                         Received 25 September 2012 Accepted 30 October 2012 phylogenetic analysis, proposed genes encod-                       Published ahead print 2 November 2012
ing gGAPDH cGAPDH isoenzymes independently                                 Address correspondence Greg Matlashewski, greg.matlashewski@mcgill.ca.
acquired trypanosomal ancestor (24). gene belongs                           Copyright Â© 2013, American Society Microbiology. Rights Reserved. trypanosome lineage origin,                           doi:10.1128/EC.00263-12
entered cell approximately 108 years ago horizontal gene


70   ec.asm.org                                         Eukaryotic Cell   p. 70 â€“77                                                 January 2013 Volume 12 Number 1
                                                                                                                                       L. donovani Cytosolic GAPDH



                                                                                     TCCTCCCTTCC 5=gacgagatctGCGCAGACAAGAAGATTGGT
                                                                                     used PCR amplify 605-bp 5=-flanking DNA fragment L.
                                                                                     donovani cGAPDH gene primers 5=gacgggatccAGTCGCTATCGCTT
                                                                                     CTCAGC 5=gacgagatctACATCGATATGCAACGACGA                                                                                      584-bp 3=-flanking DNA fragment. 605-bp 5=-flanking DNA frag-
                                                                                     ment digested HindIII BglII inserted HindIII                                                                                      BamH sites pSPY-ble (35) pSPY-hyg (40) vector (upstream                                                                                      bleomycin phosphotransferase gene hygromycin phospho-
                                                                                     transferase gene); 584-bp 3=-flanking DNA fragment digested                                                                                      BamHI BglII ligated BglII site pSPY-ble                                                                                      pSPY-hyg vector (downstream bleomycin phosphotransferase gene
                                                                                     hygromycin phosphotransferase gene). gene-targeting frag-
                                                                                     ment containing phleomycin hygromycin resistance gene flanked
                                                                                     5= 3= L. donovani cGAPDH gene-flanking sequences 
                                                                                     leased targeting vectors HindIII BglII double digestion.
                                                                                     targeting fragment DNA (5 8 â?®g) purified agarose gel                                                                                      used transfect L. donovani promastigotes primary secondary gene
                                                                                     targeting. round gene targeting, L. donovani transfectants
                                                                                     selected culture medium containing 100 â?®g/ml hygromycin.                                                                                      second-round gene targeting, single L. donovani cGAPDH gene
                                                                                     knockouts transfected phleomycin targeting construct (20
                                                                                     â?®g/ml phleomycin [Cayla]).
                                                                                         Measurement Leishmania proliferation vitro culture.                                                                                      growth curves Leishmania transfectants measured previously
                                                                                     described (33, 38, 39). Briefly, promastigotes stationary phase                                                                                      seeded concentration 2 â«» 106 cells/ml 96 plates containing
                                                                                     200 â?®l promastigote culture medium 27Â°C, pH 7.4, vitro axenic
FIG 1 Glycosomal cytosolic glycolytic pathway L. donovani. gly-           amastigote culture medium 37Â°C, pH 5.5. sample plated colytic pathway glucose 3-phosphoglycerate (3-PGA) takes place           triplicate. optical density 600 nm (OD600) values measured
mainly glycosomes. Leishmania species, L. donovani        directly plate daily 5 7 days.
L. mexicana, sixth seventh steps pathway GAP 3-PGA            Glucose consumption assay. compare glucose consumption occur cytosol, final steps lead formation     L. donovani wild-type cGAPDH-null mutant cells, log-phase promas-
pyruvate cytosolic. G6P, glucose-6-phosphate; F6P, fructose-6-phos-         tigotes suspended fresh promastigote axenic amastigote culture
phate; DHAP, dihydroxyacetone phosphate; 2-PGA, 2-phosphoglycerate.               medium containing 8 mM glucose cell density 1.5 â«» 107/ml; 200-â?®l
zymes: 1, hexokinase; 2, glucose-6-phosphate isomerase; 3, 6-phospho-1-fruc-         cultures taken culture 6 22 h, respectively; tokinase; 4, fructose-1,6-bis-phosphate aldolase; 5, triosephosphate isomerase; 6,
                                                                                     Leishmania cells removed centrifugation. glucose concentra-
glyceraldehyde 3-phosphate dehydrogenase; 7, phosphoglycerate kinase; 8, phos-
phoglycerate mutase; 9, enolase; 10, pyruvate kinase; 11, pentose phosphate path-    tion culture supernatants determined glucose assay kit
way enzymes, including glucose 6-phosphate dehydrogenase, gluconolactonase,          according manufacturerâ€™s instructions (Eton Bioscience ).
6-phosphogluconate dehydrogenase, ribulose 5-phosphate isomerase; 12,                Infection BALB/c mice. Female BALB/c mice infected tail
transketolase.                                                                       vein injection 1 â«» 108 stationary-phase promastigotes 100 â?®l PBS
                                                                                     mouse (33, 35, 36, 38, 39). weeks postinfection, amastigotes
                                                                                     isolated livers spleens infected mice. recovered
U/ml penicillin, 100-â?®g/ml streptomycin, 0.1 mM adenosine, 10 â?®g/ml                  amastigotes cultured promastigote culture medium, folic acid, 25 mM HEPES, pH 7.4. RPMI glucose medium                     Leishmania parasite burdens determined limiting dilution. prepared adding glucose (1 g/liter) mentioned RPMI                   liver parasite burdens measured counting amastigotes glucose-deficient medium.                                                            Giemsa-stained liver imprints, expressed Leishman-Donovan units
    Leishmania promastigotes routinely cultured 27Â°C, pH 7.4,              (LDU), follows: number amastigotes 1,000 cell nuclei â«» liver
glucose-rich medium. determine Leishmania proliferation dif-                weight (g) (35, 41).
ferent culture conditions, Leishmania promastigotes shifted glucose-deficient medium 37Â°C, pH 5.5, culture medium (axenic
                                                                                     RESULTS
amastigote medium) mimic macrophage phagolysosome environ-
ment associated amastigote stage (37).                                      GAPDH gene distribution sequenced Trypanosoma     Construction Leishmania expression vectors. L. donovani                   Leishmania species. Comparison trypanosomatid genomes cGAPDH gene  ortholog L. infantum cGAPDH gene,                             TriTrypDB (http://tritrypdb.org/tritrypdb) revealed se-
LinJ.36.2480) PCR amplified L. donovani genomic DNA                     quenced Trypanosoma Leishmania species contain following primers: forward primer, 5=-cccaagcttaccATGGTCAA                  copies gGAPDH genes tandem array. copy AGTGGGCATCAAC, reverse primer 1, 5=-gacgagatcTCAGCGCGC                           cGAPDH-encoding gene present L. mexicana, L.
GGACGTGTAGAGAA, reverse primer 2  fusion A2 tag),                     donovani complex species, Leishmania tarentolae, se-
5=-cgagatctgtGCGCGCGGACGTGTAGAGAA (lowercase letters repre-                          quenced Trypanosoma species. Surprisingly, cGAPDH gene,
sent restriction sites added 5= end primer). PCR
                                                                                     cytosolic phosphoglycerate kinase gene, ab-
products double digested HindIII BglII cloned pLPneo, pLGFPC, pLGFPN vectors (33, 34, 38, 39). pLGFPC                      sent L. braziliensis, cGAPDH gene pseu-
used express green fluorescent protein (GFP) fusion proteins Leish-            dogene L. major (22, 23, 42). Interestingly, L. tarento-
mania GFP N terminus; pLGFPN GFP C terminus.                  lae possesses cGAPDH gene, does cytosolic
    Constructs gene targeting. make gene-targeting constructs             phosphoglycerate kinase gene. L. infantum cGAPDH 80 L. donovani cGAPDH gene, primers 5=-gacccaagcttCTCACCTCT                     85  identity counterparts L. mexicana Trypano-


January 2013 Volume 12 Number 1                                                                                                                   ec.asm.org 71
 Zhang et al.




FIG 2 Amino acid sequence alignments L. infantum cGAPDH (Lic) (LinJ.36.2480) L. mexicana cGAPDH (Lmxc) (LmxM.36.2350), L. major
cGAPDH pseudogene product (Lmc) (LmjF.36.2350), L. infantum gGAPDH (Lig) (LinJ.30.3000). dashes represent identical amino acids; dots
represent amino acid gaps introduced better alignment. stop codon amino acid 58 L. major cGAPDH pseudogene coding sequence marked asterisk. tripeptide AKM (boldface) glycosomal targeting signal present C terminus L. infantum gGAPDH. Note following data shown: L. donovani BPK282A1 cGAPDH amino acid differences L. infantum cGAPDH (Ld:A287G:Li Ld:D302E:Li).



soma species. L. major genome sequence shows, PCR sequencing analysis confirmed stop codon present amino acid position 58 alleles cGAPDH gene L.
major. Given available ATG translation initiation site amino acid position 118, gene product miss 117-amino-acid sequence, contains NADâ«¹ binding domain critical GAPDH function. 
ingly, L. major pseudogene 82  amino acid identity L. infantum cGAPDH (Fig. 2). selective pressure retain nonfunctional sequence, suggests cGAPDH gene turned pseudogene recent evolution
event L. major. L. infantum cGAPDH shares 55  identity gGAPDH (Fig. 2). important note recent rese-
quencing L. major L. braziliensis genomes 
firmed cGAPDH gene pseudogene L. major missing L. braziliensis (23).
    Initially, necessary confirm L. donovani
cGAPDH present cytosol. Fusion proteins GFP generated expressed transfected L. don-
ovani. shown Fig. 3, expression cGAPDH-GFP fusion
proteins L. donovani (genetically closely related L. infan-
tum) confirmed cGAPDH evenly distributed L. donovani promastigotes absent nucleus kinetoplast, demonstrating enzyme confined                    FIG 3 Cytosolic localization L. donovani cGAPDH.   Western blot glycosomes.                                                                      anti-GFP antibodies showing expression cGAPDH-GFP GFP-cGAPDH
    Generation L. donovani cGAPDH-null mutant.                       fusion protein transfected L. donovani promastigotes. (B) Cytosolic local- glycolytic pathway largely occurs glycosomes cGAPDH                   ization cGAPDH-GFP GFP-cGAPDH fusion proteins L. donovani
                                                                                 promastigotes. Note L. donovani cGAPDH evenly distributed present Leishmania species, considerable                 cytosol present nucleus kinetoplast. nuclear (N) determine role cGAPDH enzyme L. don-                   kinetoplast (K) DNAs stained white 4=,6-diamidino-2-phenylindole
ovani. investigate  undertook genetic approach                   (DAPI) fluorescent dye cells. bars represent 2 â?®M.



72   ec.asm.org                                                                                                                                   Eukaryotic Cell
                                                                                                                                       L. donovani Cytosolic GAPDH




FIG 4 Generation L. donovani cGAPDH-null mutant.   Homologous
replacement strategy hygromycin bleomycin resistance gene-target-
ing constructs. black lines represent 5= 3= sequences flanking cGAPDH gene. primers used verify correct gene replacement
events sizes PCR products indicated: F, forward primer; R,
reverse primer; Hyg, hygromycin resistance gene-specific primer; Ble, bleomy-
cin resistance gene-specific primer; E, primer downstream 3=-
flanking targeting sequence. (B) PCR analysis wild-type L. donovani cells
(â«¹/â«¹), single cGAPDH-targeting (hygromycin) cell line (â«¹/â«º), double
cGAPDH replacement cell line (null mutant; â«º/â«º), primer pairs indi-        FIG 5 vitro proliferation curves L. donovani cGAPDH-null mutant cated.                                                                             glucose-containing medium added pyruvate.   Promastig-
                                                                                   ote growth curves. (B) Axenic amastigote growth curves. LdWT, wild-type L. don-
                                                                                   ovani; cGAPDHâ«º/â«º, L. donovani cGAPDH-null mutant; cGAPDHâ«º/â«ºâ«¹,
                                                                                   cGAPDH-null mutant plus L. donovani cGAPDH episomal expression
generating L. donovani cGAPDH-null mutant using gene tar-                       plasmid; cGAPDHâ«º/â«º (Pyru), cGAPDHâ«º/â«º mutant medium supple-
geting. shown Fig. 4, rounds gene targeting                      mented 1 mM pyruvate. data means triplicate OD600 values â«¾
                                                                                   standard errors mean (SEM). cell density differences successfully carried delete alleles cGAPDH gene.                wild type cGAPDH-null mutant statistically significant starting round gene targeting hygromycin resis-                 day 2 promastigote axenic amastigote cultures (*, P â¬? 0.05; **, P â¬?
tance gene-targeting construct, PCR analysis primer spe-                  0.01). data representative independent experiments.
cific hygromycin resistance gene (Hyg) primer
(E) flanking sequence downstream 3=cGAPDH obtained predicted 725-bp PCR fragment (Hyg â«¹ E), demonstrating                      cells. reduced proliferation cGAPDH-null mutant Hyg resistance gene correctly targeted                       corrected supplementing medium pyru-
cGAPDH gene alleles. Similarly, bleomycin resistance gene-tar-                   vate, suggesting growth defect result reduced
geting construct used replacing second cGAPDH gene                     capacity synthesize pyruvate cell  Discussion).
allele. shown Fig. 4B, predicted 834-bp PCR fragment                         investigate reduced proliferation cGAPDH-
(Ble â«¹ E) obtained primer specific bleomycin                    null mutant resulted factors unrelated glycolysis, resistance gene flanking primer E, demonstrating                      cGAPDH-null mutant wild-type cells cultured glu-
bleomycin resistance gene correctly targeted remaining                  cose-deficient medium direct cells use energy
cGAPDH gene allele.  expected, cGAPDH gene PCR                          sources, fatty acid, proline, threonine, previously
fragment present PCR analysis primer pairs (F                   described procyclic T. brucei (43). expected, wild
R) specific cGAPDH gene resulting L. donovani                       type cGAPDH-null mutants proliferated mutant.                                                                            slowly glucose-deficient medium glucose-containing
    Proliferation L. donovani cGAPDH-null mutant                     medium (Fig. 6).  despite lower proliferation rate,
presence absence glucose. initially compared pro-                    cGAPDH-null mutant able proliferate rate similar
liferation wild type cGAPDH-null mutant axenic                   wild-type L. donovani cells glucose-deficient
promastigotes amastigotes normal glucose-containing                      medium. indicates cGAPDH required normal
dia. shown Fig. 5, null mutant displayed significant                   proliferation glucose-containing medium, suggesting reduction proliferation compared control. Addition                    cGAPDH participates cytosolic glycolysis pathway pro- cGAPDH gene episomal vector null mutant                      vide energy optimal proliferation. able restore growth rate near level wild-type                 investigate role cGAPDH glycolysis L.


January 2013 Volume 12 Number 1                                                                                                                     ec.asm.org 73
 Zhang et al.




FIG 6 vitro growth curves L. donovani cGAPDH-null mutant promasti-
gotes medium glucose. LdWT, wild-type L. donovani;
cGAPDHâ«º/â«º, cGAPDH-null mutant; â«¹Glu, medium 1 g/liter glucose;
â«ºGlu, medium glucose. data means triplicate OD600
values â«¾ SEM. cell density differences wild type cGAPDH-null mutant statistically significant starting day 2 glu-
cose-containing culture day 3 glucose-deficient culture (*, P â¬?
0.05; **, P â¬? 0.01). data representative independent experi-
ments. Note counted cells time point microscope; cell numbers good agreement OD600 values, OD600 values appeared low glucose-deficient medium.


                                                                                  FIG 7 L. donovani cGAPDH-null mutant consumes glucose donovani, compared glucose consumption wild-type L.                     wild-type L. donovani culture medium containing glucose. Log-phase pro-
donovani, cGAPDH-null mutant, cGAPDH add                         mastigotes suspended fresh promastigote axenic amastigote culture
cells culture medium containing glucose. Equal numbers                      medium containing 8 mM glucose cell density 1.5 â«» 107/ml. Glucose
log-phase wild-type L. donovani cells cGAPDH mutants                      concentrations media culture 6 22 h determined.  
                                                                                  Glucose consumption promastigote culture. (B) Glucose consumption suspended fresh axenic promastigote amastigote cul-                    axenic amastigote culture. LdWT, wild-type L. donovani; cGAPDHâ«º/â«º,
ture medium, glucose consumption determined mea-                       cGAPDH-null mutant; cGAPDHâ«º/â«ºâ«¹, cGAPDH-null mutant plus L.
suring glucose concentrations culture medium 6                   donovani cGAPDH episomal expression plasmid. data means 22 h. shown Fig. 7, 6 h, glucose concentration                glucose concentrations triplicate cultures â«¾ SEM. glucose concentra- slightly lower wild-type L. donovani cGAPDH add-                    tion differences culture media wild type cGAPDH-null
                                                                                  mutant statistically significant culture 22 h promastigote cell cultures cGAPDH-null mutant culture.                        culture axenic amastigote culture (*, P â¬? 0.05; **, P â¬? 0.01). data  significant difference glucose concentration                  representative independent experiments. observed culture 22 h. cGAPDH-null mutant
utilizes glucose wild-type cGAPDH add cells promastigote axenic amastigote culture, strongly sug-                    placed glucose-containing glucose-deficient medium. Inter-
gesting cGAPDH involved glycolysis L. donovani.                     estingly, glucose-containing medium, presence cGAPDH
    L. donovani cGAPDH-null mutant displays reduced                        suppressed L. major proliferation reduced cell density sta-
fectivity visceral organs. examine L. donovani                   tionary phase compared control (Fig. 9). contrast, quires cGAPDH survival visceral organs, BALB/c mice                   proliferation L. major containing cGAPDH similar infected wild-type cGAPDH-null mutant promastigotes                      control glucose-deficient medium. indicates  intravenous injection, infection levels determined                unlike L. donovani, cGAPDH activity beneficial 4 weeks. shown Fig. 8, liver spleen parasite                  harmful L. major. cGAPDH-containing L. major consumed
burdens mice infected cGAPDH-null mutant                         glucose control transfected L. major glucose-
significantly reduced compared wild-type L. donovani                      containing culture medium, adverse
fected mice. Addition cGAPDH gene episomal vector                    effect cGAPDH L. major (data shown). null mutant able partially restore infectivity,
confirming requirement cGAPDH visceral organ sur-                      DISCUSSION
vival.                                                                            glycolytic pathway glucose 3-phosphoglycerate
    Restoration cGAPDH activity suppressed L. major prolif-                    place exclusively glycosomes, clear eration glucose-containing, glucose-deficient,                      cytosolic counterpart GAPDH present Leishma-
dium. Unlike L. donovani, cGAPDH gene                         nia species, L. donovani. study, demonstrate pseudogene L. major (Fig. 2). interesting                  deletion L. donovani cGAPDH gene reduced glucose uptake,
investigate restoring cGAPDH activity L. major                   suppressed proliferation glucose-containing medium, 
result increased proliferation presence glucose.                  significantly, attenuated survival visceral organs. episomal expression vector containing L. donovani cGAPDH                      observations indicate cGAPDH gene L. donovani gene transfected L. major, transfectants                    functional plays role visceral disease pathogenesis.


74   ec.asm.org                                                                                                                                    Eukaryotic Cell
                                                                                                                                      L. donovani Cytosolic GAPDH




                                                                                FIG 9 vitro promastigote proliferation curves L. major containing L.
                                                                                donovani cGAPDH gene (Lmâ«¹cGAPDH) control transfected L. major (Lm
                                                                                neo) medium (â«¹Glu) (â«ºGlu) glucose. data means
                                                                                triplicates â«¾ SEM. cell density differences Lmâ«¹cGAPDH Lm
                                                                                neo statistically significant starting day 3 glucose-containing culture
                                                                                (*, P â¬? 0.05; **, P â¬? 0.01). data representative independent exper-
FIG 8 L. donovani cGAPDH-null mutant displayed reduced infectivity       iments. livers spleens BALB/c mice. L. donovani cGAPDH mutants used infect BALB/c mice tail vein injection (5 mice group); 4 weeks infection, mice examined liver spleen parasite burden.
  Liver parasite burden. (B) Spleen parasite burden. LdWT, wild-type L.       phosphoenolpyruvate (PEP) generated glycolysis enters donovani; cGAPDHâ«º/â«º, cGAPDH-null mutant; cGAPDHâ«º/â«ºâ«¹, cGAPDH-                    glycosome fermented succinate regenerate ATP
null mutant plus L. donovani cGAPDH episomal expression plasmid.        NADâ«¹ consumed upper glycolytic pathway reactions, data means plus SEM. LDU spleen parasite burden differences statistically significant (P â¬? 0.01) mice infected         C4 dicarboxylic acids generated succinate fer-
cGAPDH-null mutant mice infected wild-type parasites            mentation catabolized tricarboxylic acid (TCA)
cGAPDH add mutant. experiment repeated times sim-         cycle (32). explain cGAPDH-null mutant pro-
ilar results.                                                                   liferation rate improved supplementing medium
                                                                                pyruvate, shown Fig. 5.
                                                                                    suggested proteomic analysis dif-
    previously observed glycolytic intermediates               ferentiation extracellular promastigotes intracellular equilibrate glycosome membranes cytosol                 amastigotes, Leishmania parasites shift glucose amino ac-
(28).  recent study suggested glycosome mem-                   ids fatty acids main energy sources (45). 
brane contains types pore-forming channels allow                studies shown glucose amino sugars movement small solutes membrane, including inter-                 required amastigote stage, mainly
mediate metabolites glycolysis molecular masses 300               needed formation glycoconjugates (46â€“49). Leishmania 400 Da (27). observations study,               amastigotes able utilize amino sugars phagolysosome
parallel glycolytic pathway beginning sixth step glycol-            mammalian macrophages source carbon energy
ysis place cytosol Leishmania species            (47). Interestingly, gene deletion study gluconeogenic 
expressing cGAPDH (Fig. 1). silico analysis glycolytic              zyme fructose-1,6-bisphosphatase (FBP) showed Leishmania flux bloodstream form T. brucei shows GAPDH                    requires gluconeogenesis virulence (50). GAPDH enzymes play role control glycolytic                 able catalyze reverse reaction 3-phospho-D-glyc-
pathway (9â€“11), presence partial parallel glycolytic                 eroyl phosphate GAP gluconeogenesis. observation pathway L. donovani cytosol increase overall gly-              study L. donovani cGAPDH-null mutant reduced
colytic flux generation ATP. partial parallel               infectivity visceral organs suggests cGAPDH 
glycolytic pathway help balance cytosolic NADâ«¹/                 volved glycolysis gluconeogenesis pathways L.
NADH ratio. study, observed growth                   donovani resides amastigote macrophage phagolyso- L. donovani cGAPDH-null mutants appeared pro-                     sugar levels relatively low (47, 51).
foundly affected late log stationary phases                  available crystal structures T. brucei, T. cruzi, L.
early log phase (Fig. 5 6). fact          mexicana gGAPDHs enabled design inhibitors fast-growing Leishmania cells log phase require active                  effectively block trypanosomatid gGAPDH, lethal
glycolytic flux GAPDH activity energy production (11,                   bloodstream T. brucei intracellular T. cruzi (10, 15â€“17). 44), accumulating effect makes cell density difference              bloodstream stage T. brucei uses glycolysis energy obvious late log stationary phases early log                source cytosolic phosphoglycerate kinase expression phase.                                                                          suppressed, explain inhibitors gGAPDH     recent glucose metabolic labeling study L. mexicana pro-               lethal bloodstream T. brucei.  unknown mastigotes shown  instead converted pyru-                gGAPDH inhibitors inhibit cGAPDH vate, usual final product aerobic glycolysis, majority            lethal L. mexicana (10). 

January 2013 Volume 12 Number 1                                                                                                                    ec.asm.org 75
 Zhang et al.



observations study, appropriate develop                       submicromolar, biologically active inhibitors trypanosomatid glyceral-
inhibitors cGAPDH L. donovani, null mutant                       dehyde-3-phosphate dehydrogenase. Proc. Natl. Acad. Sci. U. S.  96:
                                                                                     4273â€“ 4278.
significantly attenuated visceral organs.  ideal             11.   ter Kuile BH. 1999. Regulation adaptation glucose metabolism hibitor capable blocking glycosomal                        parasitic protist Leishmania donovani enzyme mRNA levels.
cytosolic GAPDH activities. difficult single                      J. Bacteriol. 181:4863â€“ 4872.
inhibitor, enzymes share 55  homology.                          12.   Kim H, Feil IK, Verlinde CL, Petra PH, Hol  1995. Crystal structure
    clear cGAPDH gene evolved pseu-                     glycosomal glyceraldehyde-3-phosphate dehydrogenase Leishma-
                                                                                     nia mexicana: implications structure-based drug design new
dogene L. major absent L. braziliensis present L.                position inorganic phosphate binding site. Biochemistry 34:
donovani L. mexicana. Unlike Leishmania species, L.                        14975â€“14986.
braziliensis does cytosolic phosphoglycerate kinase              13.   Souza DH, Garratt RC, AraÃºjo AP, GuimarÃ£es BG, Jesus WD, Michels
(cPGK). present study, expected introduc-                     PA, Hannaert V, Oliva G. 1998. Trypanosoma cruzi glycosomal glycer-
                                                                                     aldehyde-3-phosphate dehydrogenase: structure, catalytic mechanism
tion L. donovani cGAPDH L. major result                                                                                      targeted inhibitor design. FEBS Lett. 424:131â€“135.
adverse effect proliferation glucose-containing medium.                  14.   Vellieux FM, Hajdu J, Hol  1995. Refined 3.2 structure glyco- provide rationale gene evolved                     somal holo glyceraldehyde phosphate dehydrogenase Trypanosoma pseudogene L. major.                                                       brucei brucei. Acta Crystallogr. D Biol. Crystallogr. 51:575â€“589.
    principal function GAPDH catalyze sixth step              15.   Callens M, Hannaert V. 1995. rational design trypanocidal drugs:
                                                                                     selective inhibition glyceraldehyde-3-phosphate dehydrogenase glycolysis produce energy carbon molecules. addition,                   Trypanosomatidae. Ann. Trop. Med. Parasitol. 89(Suppl. 1):23â€“30.
GAPDH recently implicated nonmetabolic                     16.   Suresh S, Bressi JC, Kennedy KJ, Verlinde CL, Gelb MH, Hol 
processes higher eukaryotic cells, including transcription acti-                  2001. Conformational changes Leishmania mexicana glyceraldehyde-
vation, initiation apoptosis, endoplasmic reticulum (ER)-                     3-phosphate dehydrogenase induced designed inhibitors. J. Mol. Biol. Golgi apparatus vesicle shuttling (52, 53). indication                      309:423â€“ 435.
                                                                               17.   Verlinde CL, Hannaert V, Blonski C, Willson M, PÃ©riÃ© JJ, Fothergill-
GAPDH involvement nonmetabolic processes higher eu-                            Gilmore LA, Opperdoes FR, Gelb MH, Hol  Michels PA. 2001.
karyotic cells translocation enzyme nucleus                  Glycolysis target design new anti-trypanosome drugs. Drug
response cellular stress (53). studies showed                  Resist. Updat. 4:50 â€“ 65. translocation nucleus L. donovani GFP-cGAPDH                   18.   Hannaert V, Blaauw M, Kohl L, Allert S, Opperdoes FR, Michels PA.
                                                                                     1992. Molecular analysis cytosolic glycosomal glyceraldehyde-
fusion proteins (Fig. 3) Leishmania cells exposed                    3-phosphate dehydrogenase Leishmania mexicana. Mol. Biochem. cellular stress, serum withdrawal stress induced                    Parasitol. 55:115â€“126.
exposure hydrogen peroxide (data shown). neverthe-                19.   Lambeir M, Loiseau  Kuntz DA, Vellieux FM, Michels PAM, possible rule possibility L. donovani                       Opperdoes FR. 1991. cytosolic glycosomal glyceraldedehyde-3-
cGAPDH plays roles independent glycolysis.                                   phosphate dehydrogenase Trypanosoma brucei: kinetic properties
                                                                                     comparison homologous enzymes. Eur. J. Biochem. 198:429 â€“
                                                                                     435.
ACKNOWLEDGMENTS                                                                20.   Misset O, Van Beeumen J, Lambeir Van der Meer MR, Opperdoes study supported operating grant Canadian Insti-              FR. 1987. Glyceraldehydephosphate dehydrogenase Trypanosoma
tute Health Research (CIHR). L. M. acknowledges receiving                brucei. Comparison glycosomal cytosolic isoenzymes. Eur. J.
                                                                                     Biochem. 162:501â€“507.
graduate scholarship CIHR.
                                                                               21.   Michels PA, Poliszczak  Osinga KA, Misset O, Van Beeumen J,
                                                                                     Wierenga RK, Borst P, Opperdoes FR. 1986. tandemly linked
REFERENCES                                                                           identical genes code glycosomal glyceraldehyde-phosphate dehy-
 1. GualdrÃ³n-LÃ³pez M, Brennand  Hannaert V, QuiÃ±ones W, CÃ¡ceres                    drogenase Trypanosoma brucei. EMBO J. 5:1049 â€“1056.
    AJ, Bringaud F, ConcepciÃ³n JL, Michels PA. 2012.          22.   Peacock CS, Seeger K, Harris D, Murphy L, Ruiz JC, Quail MA, Peters
    glycolysis compartmentalised Kinetoplastea. new look          N, Adlem E, Tivey  Aslett M, Kerhornou  Ivens  Fraser 
    ancient organelle. Int. J. Parasitol. 42:1â€“20.                                Rajandream MA, Carver T, Norbertczak H, Chillingworth T, Hance 
 2. Hannaert V, Bringaud F, Opperdoes FR, Michels PAM. 2003. Evolution               Jagels K, Moule S, Ormond D, Rutter S, Squares R, Whitehead
    energy metabolism compartmentation Kinetoplastida. Ki-             S, Rabbinowitsch E, Arrowsmith C, White B, Thurston S, Bringaud F,
    netoplastid Biol. Dis. 2:11.                                                     Baldauf SL, Faulconbridge  Jeffares D, Depledge DP, Oyola 
 3. Hannaert V, Michels PAM. 1994. Structure, function, biogenesis            Hilley JD, Brito LO, Tosi LR, Barrell B, Cruz AK, Mottram JC, Smith
    glycosomes Kinetoplastida. J. Bioenerg. Biomembr. 26:205â€“212.                 DF, Berriman M. 2007. Comparative genomic analysis Leishma-
 4. Michels PA, Bringaud F, Herman M, Hannaert V. 2006. Metabolic                    nia species cause diverse human disease. Nat. Genet. 39:839 â€“ 847.
    functions glycosomes trypanosomatids. Biochim. Biophys. Acta         23.   Rogers MB, Hilley JD, Dickens NJ, Wilkes J, Bates PA, Depledge DP,
    1763:1463â€“1477.                                                                  Harris D, Y, Herzyk P, Imamura H, Otto TD, Sanders M, Seeger
 5. Michels PA, Hannaert V, Bringaud F. 2000. Metabolic aspects glyco-            K, Dujardin JC, Berriman M, Smith DF, Hertz-Fowler C, Mottram JC.
    somes Trypanosomatidaeâ€”new data views. Parasitol. Today 16:               2011. Chromosome gene copy number variation allow major struc-
    482â€“ 489.                                                                        tural change species strains Leishmania. Genome Res.
 6. Opperdoes FR. 1987. Compartmentation carbohydrate metabolism               21:2129 â€“2142.
    trypanosomes. Annu. Rev. Microbiol. 41:127â€“151.                            24.   Michels PA, Marchand M, Kohl L, Allert S, Wierenga RK, Opperdoes
 7. Opperdoes FR, Borst P. 1977. Localization glycolytic enzymes          FR. 1991. cytosolic glycosomal isoenzymes glyceraldehyde-3-
    microbody-like organelle Trypanosoma brucei: glycosome. FEBS            phosphate dehydrogenase Trypanosoma brucei distant evolu-
    Lett. 80:360 â€“364.                                                               tionary relationship. Eur. J. Biochem. 198:421â€“ 428.
 8. Parsons M. 2004. Glycosomes: parasites divergence peroxi-       25.   Lake JA, la Cruz V, Ferreira PCG, Morel C, Simpson L. 1988.
    somal purpose, Mol. Microbiol. 53:717â€“724.                                       Evolution parasitism: kinetoplastid protozoan history reconstructed
 9. Albert MA, Haanstra JR, Hannaert V, Van Roy J, Opperdoes FR,                     mitochondrial rRNA gene sequences. Proc. Natl. Acad. Sci. U. S. 
    Bakker BM, Michels PA. 2005. Experimental silico analyses              85:4779 â€“ 4783.
    glycolytic flux control bloodstream form Trypanosoma brucei. J. Biol.   26.   Wiemer EA, Hannaert V, van den IJssel PR, Van Roy J, Opperdoes FR,
    Chem. 280:28306 â€“28315.                                                          Michels PA. 1995. Molecular analysis glyceraldehyde-3-phosphate 
10. Aronov  Suresh S, Buckner FS, Van Voorhis WC, Verlinde CL,                    hydrogenase Trypanoplasma borelli: evolutionary scenario sub-
    Opperdoes FR, Hol  Gelb MH. 1999. Structure-based design                   cellular compartmentation kinetoplastida. J. Mol. Evol. 40:443â€“ 454.



76   ec.asm.org                                                                                                                                 Eukaryotic Cell
                                                                                                                                       L. donovani Cytosolic GAPDH



27. Gualdron-Lopez M, Vapola MH, Miinalainen IJ, Hiltunen JK, Michels                   bacterial DNA plasmid oligomers Leishmania. Mol. Biochem. Parasitol.
    PAM, Antonenkov VD. 2012. Channel-forming activities glyco-                  65:39 â€“ 49.
    somal fraction bloodstream form Trypanosoma brucei. PLoS          41.   Zhang WW, Mendez S, Ghosh  Myler P, Ivens  Clos J, Sacks DL,
    7:e34530. doi:10.1371/journal.pone.0034530.                                     Matlashewski G. 2003. Comparison A2 gene locus Leishmania
28. Visser N, Opperdoes FR, Borst P. 1981. Subcellular compartmentation                 donovani Leishmania major control cutaneous infection.
    glycolytic intermediates Trypanosoma brucei. Eur. J. Biochem. 118:            J. Biol. Chem. 278:35508 â€“35515.
    521â€“526.                                                                      42.   Raymond F, Boisvert S, Roy G, Ritt JF, LÃ©garÃ© D, Isnard  Stanke M,
29. Kaur PK, Dinesh N, Soumya N, Babu NK, Singh S. 2012. Identification                 Olivier M, Tremblay MJ, Papadopoulou B, Ouellette M, Corbeil J.
    characterization novel ribose 5-phosphate isomerase B                 2012. Genome sequencing lizard parasite Leishmania tarentolae
    Leishmania donovani. Biochem. Biophys. Res. Commun. 421:51â€“56.                      reveals loss genes associated intracellular stage human patho-
30. Maugeri DA, Cazzulo JJ, Burchmore RJ, Barrett MP, Ogbunude PO.                      genic species. Nucleic Acids Res. 40:1131â€“1147.
    2003. Pentose phosphate metabolism Leishmania mexicana. Mol.               43.   Lamour N, RiviÃ¨re L, Coustou V, Coombs GH, Barrett MP, Bringaud
    Biochem. Parasitol. 130:117â€“125.                                                    F. 2005. Proline metabolism procyclic Trypanosoma brucei 
31. Blattner J, Helfert S, Michels P, Clayton C. 1998. Compartmentation              regulated presence glucose. J. Biol. Chem. 280:11902â€“11910.
    phosphoglycerate kinase Trypanosoma brucei plays critical role        44.   Mukkada AJ, Schaefer FW, III, Simon MW, Neu C. 1974. Delayed     parasite energy metabolism. Proc. Natl. Acad. Sci. U. S.  95:11596 â€“              vitro utilization glucose Leishmania tropica promastigotes. J. Proto-
    11600.                                                                              zool. 21:393â€“397.
32. Saunders EC, Ng WW, Chambers JM, Ng M, Naderer T, KrÃ¶mer JO,                  45.   Rosenzweig D, Smith D, Opperdoes F, Stern S, Olafson RW, Zilberstein
    Likic VA, McConville MJ. 2011. Isotopomer profiling Leishmania                   D. 2008. Retooling Leishmania metabolism: sand fly gut human
    mexicana promastigotes reveals important roles succinate fermenta-              macrophage. FASEB J. 22:590 â€“ 602.
    tion aspartate uptake tricarboxylic acid cycle (TCA) anaplerosis,      46.   Burchmore RJ, Rodriguez-Contreras D, McBride K, Merkel P, Barrett
    glutamate synthesis, growth. J. Biol. Chem. 286:27706 â€“27717.                   MP, Modi G, Sacks D, Landfear SM. 2003. Genetic characterization 33. Zhang WW, Chan KF, Song  Matlashewski G. 2011. Expression                    glucose transporter function Leishmania mexicana. Proc. Natl. Acad.
    Leishmania donovani nucleotide sugar transporter Leishmania major                Sci. U. S.  100:3901â€“3906.
    enhances survival visceral organs. Exp. Parasitol. 129:337â€“345.            47.   Naderer T, Heng J, McConville MJ. 2010. Evidence intracellular
34. Zhang WW, Charest H, Matlashewski G. 1995. expression bio-                   stages Leishmania major utilize amino sugars major carbon source.
    logically active human p53 Leishmania cells: novel eukaryotic           PLoS Pathog. 6:e1001245. doi:10.1371/journal.ppat.1001245.
    produce recombinant proteins. Nucleic Acids Res. 23:4073â€“ 4080.            48.   Rodriguez-Contreras D, Feng 